Healthtech Startups

Covera Health applies AI to measure and improve care quality, providing quality insights used by healthcare providers and payers. The company focuses on defining, measuring, and delivering higher standards of care for patients.

3 investors

Craniometrix provides AI-powered care navigation and support services to help dementia patients remain at home while reducing hospitalizations for their families and caregivers.

3 investors

Cresilon develops plant-based flowable hemostatic gel technology that controls bleeding within seconds without manual pressure, with products for veterinary care (VETIGEL) and human trauma (TRAUMAGEL). Its customers include EMS agencies, trauma hospitals, military, law enforcement, and veterinary practices.

3 investors

Cricket Health provides value-based kidney care, using a holistic approach to treat people with chronic kidney disease and related cardiovascular conditions. It works with payers and nephrologists to advance health equity and improve outcomes for patients with chronic conditions.

3 investors

CrowdMed connects patients with a community of medical experts ("Medical Detectives") to help solve complex, undiagnosed medical cases through crowdsourced diagnostic suggestions. Patients submit their medical history and symptoms, receive a report with top diagnostic recommendations, and can present these insights to their physicians for testing.

3 investors

Cryogenx develops CGX1, a portable body cooling device designed to treat heatstroke and prevent heat-related deaths. The company targets defense, first responder, sports, and industrial sectors with medical technology intended to rapidly reduce core body temperature.

3 investors

RejuvenAir, developed by CSA Medical, is a bronchoscopic cryosurgical device that sprays metered doses of liquid nitrogen to destroy damaged airway cells and treat the underlying cause of COPD with Chronic Bronchitis. The investigational device is being evaluated in the SPRAY-CB clinical trial at hospitals across the United States for interventional pulmonary care.

3 investors

Curative offers an employer-sponsored health insurance plan with $0 copays, $0 deductibles, and a single monthly premium, giving members access to a nationwide provider network, telehealth, and $0 preferred prescriptions. The plan includes a cash card for out-of-pocket-free care and support from care navigators to help members manage their health.

3 investors

CURE operates a booking platform that connects pharmacies with delivery service partners to generate online orders. The platform provides integration with point-of-sale systems, product data management, and marketing campaigns for German-speaking pharmacies.

3 investors

Cure51 is a cancer research company that decodes the biology of exceptional cancer survivors ("cancer outliers") using molecular profiling and computational biology, collecting patient data on its Patient Profile Platform. It works with cancer centers and clinical partners as part of the Rosalind Study to advance cancer research.

3 investors

CurifyLabs develops an automated compounding system for pharmacies that uses robotics, GMP-manufactured excipient bases, and integrated quality control software to enable faster, safer preparation of customized medications. The platform serves hospital and retail pharmacies in Europe and the US, particularly for underserved patient populations including children and cancer patients.

3 investors

Current Foods produces plant-based and biotech-derived seafood products, including raw tuna and smoked salmon alternatives, designed to compete on flavor, nutritional profile, cost, and supply reliability. The company targets consumers seeking sustainable seafood options without sacrificing taste or health benefits.

3 investors

Current Health builds FDA-cleared clinical technology and infrastructure that enables acute and complex care—including advanced therapies like CAR-T, bispecifics, and cell and gene therapies—to be delivered safely in ambulatory and home settings. It works with health systems and global pharmaceutical companies to expand patient access to high-cost treatments outside traditional hospital settings.

3 investors

Current Surgical develops a smart needle technology platform for surgical treatment of cancerous tumors. The company serves surgeons and oncologists in the medical device and cancer care space.

3 investors

Cyfuse Bio develops 3D cell-based tissue and organ products created from cells alone, without artificial materials, for transplantation to restore original tissue and organ function in regenerative medicine applications.

3 investors

Vivante Health offers a digital platform providing clinician-backed, personalized care for digestive and gastrointestinal health, covering issues from bloating and women's digestive health to chronic conditions like IBS and IBD. Its services include microbiome testing, custom diet and lifestyle plans, tracking tools, and access to a team of gastroenterologists, dietitians, and health coaches.

3 investors

Cyteir is a clinical-stage oncology company developing CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters. Its lead program is being studied in combination with capecitabine and gemcitabine in a Phase 1/2 clinical trial that includes patients with advanced ovarian cancer.

3 investors

Cytek Biosciences develops high-parametric analytical instruments and software that enable scientists at pharmaceutical companies, contract research organizations, and academic institutions to generate and analyze biological datasets. The company serves the life sciences research and drug development sectors.

3 investors

CytomX is a clinical-stage biopharmaceutical company developing conditionally activated biologic cancer therapies, including antibody-based treatments designed to target tumors while limiting effects on healthy tissue. It advances a pipeline of Probody therapeutics through preclinical research and clinical trials in oncology.

3 investors

DAAN Biotherapeutics develops T-cell immunotherapies for cancer, including TCR-T cell therapies, TCR-mimic T-cell engagers, and conditionally activated T-cell engagers targeting tumor-specific antigens. The company is building an immuno-oncology pipeline aimed at improving precision and reducing toxicity for patients with cancer.

3 investors

Darmiyan develops medical AI and brain imaging software for early detection and monitoring of neurodegenerative diseases, particularly Alzheimer's. The platform targets healthcare providers, patients, and pharmaceutical companies seeking to advance brain health and disease prevention.

3 investors

Dashlabs.ai builds practice management and lab information software for diagnostic laboratories, featuring billing, appointment scheduling, instrument integration for automated test result generation, medical imaging support, and secure result distribution to employers and staffing agencies.

3 investors

Data-Driven Bioscience develops Duoseq, a cancer genomics platform that performs simultaneous DNA and RNA analysis from a single sample, delivering comprehensive molecular profiling results in two days for use in clinical diagnostics and research.

3 investors

DSI provides scientific services for preclinical research, including implanted telemetry support, in vivo study execution, data analysis and reporting, and GLP validation. It serves researchers and laboratories conducting physiological studies such as cardiovascular and respiratory monitoring in animal models.

3 investors